Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.37 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10676732 | 0.89 | GRM4 (0.39) | ALDH1A1TSHRHSD17B10GRM4HDAC1 | |
| SCHEMBL10679605 | 0.86 | GRM4 (0.38) | ALDH1A1TSHRHSD17B10GRM4HDAC1 | |
| SCHEMBL19767056 | 0.85 | CHRNB2 (0.37) | GRM4HDAC1HDAC6HDAC5CHRNB2 | |
| SCHEMBL17992208 | 0.83 | GRM4 (0.36) | GRM4HDAC1HDAC6HDAC5CHRNB2 | |
| SCHEMBL4549587 | 0.81 | ALDH1A1 (0.47) | ALDH1A1TSHRHSD17B10CHRNB2CHRNB4 | |
| SCHEMBL2302955 | 0.80 | SLC7A5 (0.48) | GRM4CHRNB2CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL29411244 | 0.80 | SLC7A5 (0.48) | GRM4CHRNB2CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL11679555 | 0.79 | ALDH1A1 (0.69) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL2303010 | 0.78 | GRM4 (0.41) | GRM4HDAC1HDAC6HDAC5CHRNB2 | |
| SCHEMBL10329123 | 0.78 | GRM4 (0.41) | GRM4HDAC1HDAC6HDAC5CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10173997-B2 | Bipyridine compound and use of same for noxious arthropod control | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-01-08 | — | — | US | disclosed |
| WO-2017073733-A1 | PEST CONTROL COMPOSITION AND USE THEREOF | 住友化学株式会社 | 2017-05-04 | — | — | WO | disclosed |
| WO-2016121969-A1 | BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | 住友化学株式会社 | 2016-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10173997-B2 | Bipyridine compound and use of same for noxious arthropod control | BBOX1, ACHE, MORF4L1 | ALDH1A1 2823/4885TSHR 3736/4885HSD17B10 4281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.